The British Thoracic Society (BTS) guidelines for the management of community-acquired pneumonia in children are used as the audit standard for the annual BTS Paediatric Pneumonia Audit. This report examines 3 years of data from this national audit, highlighting trends in clinical practice and the impact of the 2011 revisions to the BTS guidelines. The findings suggest an over-reliance on investigations to diagnose pneumonia and underuse of oral antibiotics, particularly amoxicillin. There is inappropriate use of chest physiotherapy, outpatient appointments and repeat chest x-rays. Increasing adherence to the BTS guidelines would improve care and also preserve valuable secondary care resources.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/thoraxjnl-2012-203026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nontuberculous Mycobacterial Infections: A Retrospective Analysis From a Tertiary Hospital in Portugal.
Cureus
November 2024
Pulmonology, Unidade Local de Saúde Amadora/Sintra, Amadora, PRT.
Introduction The prevalence of nontuberculous mycobacteria (NTM) is higher in patients with structural lung disease and in immunocompromised patients. Lung involvement is the most common. The complex corresponds to the most identified agent.
View Article and Find Full Text PDFImproving Compliance With Valid Oxygen Prescriptions for Surgical Inpatients in a District General Hospital: A Single-Centre Quality Improvement Study.
Cureus
October 2024
Department of Surgery, Royal Blackburn Teaching Hospital, Blackburn, GBR.
Introduction Medical oxygen is a drug and, as such, must be correctly prescribed according to British Thoracic Society (BTS) guidelines. These guidelines state that a valid prescription must include a target oxygen saturation range, and that all inpatients should have a valid oxygen prescription. A 2008 BTS audit revealed only 32% of patients receiving oxygen had valid prescriptions, and a 2015 re-audit showed improvement to 57.
View Article and Find Full Text PDFHigh-Dose Oxygen Therapy and Acute Hypercapnia in Elderly Patients: A Case Series Analysis.
Am J Case Rep
November 2024
Medical Professorial Unit, St Vincent's University Hospital, Dublin, Ireland.
Article Synopsis
- Elderly individuals are frequently detected with episodes of low blood oxygen levels (desaturation) in community settings, leading to increased ambulance transfers and high-dose inhaled oxygen therapy (FiO₂ > 50%).
- Current guidelines recommend administering oxygen via non-rebreather masks for low oxygen saturation, but this can cause dangerous levels of carbon dioxide retention (hypercapnia) in some elderly patients without known risk factors.
- A case series highlights three elderly patients who developed acute hypercapnia after receiving high-dose oxygen therapy, indicating that healthcare providers must consider the risk of oxygen-induced CO₂ retention to improve patient outcomes and resource use.
Iatrogenic Haemothorax: A Life-Threatening Complication Following A 12Fg Seldinger Intercostal Drain Insertion for Pneumothorax.
Eur J Case Rep Intern Med
October 2024
Respiratory Department, Barnsley District General Hospital, Barnsley, UK.
Unlabelled: A man in his 30s with no previous medical history presented to the emergency department with acute dyspnoea. His chest X-ray (CXR) showed a massive left-sided pneumothorax, and a 12Fg post-intercostal drain (ICD) was inserted. Twenty-four hours later there was evidence of blood in the drain, and he had a significant haemoglobin drop of 44 g/l in only one day.
View Article and Find Full Text PDFSouth African Rheumatism and Arthritis Association 2024 guidelines for the use of biologic and targeted synthetic disease-modifying antirheumatic drugs.
S Afr Med J
September 2024
Rheumatology Division, Department of Medicine, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, South Africa.
Biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) target a specific pathway of the immune system, and are usually prescribed after failure of conventional synthetic disease-modifying antirheumatic drug therapy. The choice of b/tsDMARD depends on the disease profile and comorbidities, patient preference, registered indications of the drugs, and risks associated with therapy. It is recommended that b/tsDMARDs for immune-mediated inflammatory rheumatic diseases are prescribed by a rheumatologist, and all patients must be included in the South African Rheumatism and Arthritis Association biologic registry.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!